Comparison of an Electronic Glycemic Management System Versus Provider-Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital Setting
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Background: American Diabetes Association (ADA) guidelines recommend a basal bolus correction insulin regimen as the preferred method of treatment for non–critically ill hospitalized patients. However, achieving ADA glucose targets safely, without hypoglycemia, is challenging. In this study we evaluated the safety and efficacy of basal bolus subcutaneous (SubQ) insulin therapy managed by providers compared to a nurse-directed Electronic Glycemic Management System (eGMS). Method: This retrospective crossover study evaluated 993 non-ICU patients treated with subcutaneous basal bolus insulin therapy managed by a provider compared to an eGMS. Analysis compared therapy outcomes before Glucommander (BGM), during Glucommander (DGM), and after Glucommander (AGM) for all patients. The blood glucose (BG) target was set at 140-180 mg/dL for all groups. The safety of each was evaluated by the following: (1) BG averages, (2) hypoglycemic events <40 and <70 mg/dL, and (3) percentage of BG in target. Result: Percentage of BG in target was BGM 47%, DGM 62%, and AGM 36%. Patients’ BGM BG average was 195 mg/dL, DGM BG average was 169 mg/dL, and AGM BG average was 174 mg/dL. Percentage of hypoglycemic events <70 mg/dL was 2.6% BGM, 1.9% DGM, and 2.8% AGM treatment. Conclusion: Patients using eGMS in the DGM group achieved improved glycemic control with lower incidence of hypoglycemia (<40 mg/dL and <70 mg/dl) compared to both BGM and AGM management with standard treatment. These results suggest that an eGMS can safely maintain glucose control with less hypoglycemia than basal bolus treatment managed by a provider.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Automated, computerized, IV insulin protocols, including commercially available or institutional-based protocols, have improved glycemic control, with good acceptance by nursing personnel.1294–1307”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1300]
In the citing paper
“Currently available commercial electronic glucose management systems may facilitate implementation of insulin protocols in the hospital (13,14).”
From 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026 (2026) · cites this paper as [13]
Citations
Cites
Umpierrez, G. E., Hellman, R., Korytkowski, M. T., Kosiborod, M., Maynard, G. A., Montori, V. M., Seley, J. J., & Van den Berghe, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2098 · Cited by 1,126
Umpierrez, G. E., Smiley, D., Jacobs, S., Peng, L., Temponi, A., Mulligan, P., Umpierrez, D., Newton, C., Olson, D., & Rizzo, M. (2011) · Diabetes Care · doi:10.2337/dc10-1407 · Cited by 720
Umpierrez, G. E., Smiley, D., Zisman, A., Prieto, L. M., Palacio, A., Ceron, M., Puig, A., & Mejia, R. (2007) · Diabetes Care · doi:10.2337/dc07-0295 · Cited by 671
Moghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E. (2009) · Endocrine Practice · doi:10.4158/ep09102.ra · Cited by 518
Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward
Turchin, A., Matheny, M. E., Shubina, M., Scanlon, J. V., Greenwood, B., & Pendergrass, M. L. (2009) · Diabetes Care · doi:10.2337/dc08-2127 · Cited by 453
Umpierrez, G., Cardona, S., Pasquel, F., Jacobs, S., Peng, L., Unigwe, M., Newton, C. A., Smiley-Byrd, D., Vellanki, P., Halkos, M., et al. (2015) · Diabetes Care · doi:10.2337/dc15-0303 · Cited by 281
Sliding Scale Insulin Use: Myth or Insanity?
Umpierrez, G. E., Palacio, A., & Smiley, D. D. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.05.070 · Cited by 155
(2015) · Diabetes Care · doi:10.2337/dc16-s001 · Cited by 140
Sliding Scale Insulin—Time to Stop Sliding
Hirsch, I. B. (2009) · JAMA · doi:10.1001/jama.2008.943 · Cited by 136
Clinical Considerations for Use of Initial Combination Therapy in Type 2 Diabetes
Cahn, A., & Cefalu, W. T. (2016) · Diabetes Care · doi:10.2337/dcs15-3007 · Cited by 118
Research works printed but not linked: 7
- Tanenberg R., 2013, Paper presented at: 73rd ADA Scientific Sessions
- Davidson P, 2012, Paper presented at: AACE
- Mabrey M, 2015, Paper presented at: AACE
- Aloi J, 2015, Paper presented at: AACE
- Aloi J, 2015, Paper presented at: ADA
- Ullal J, 2015, Paper presented at: DTM
- Mabrey M, 2015, Paper presented at: IHDM
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
McCall, A. L., Lieb, D. C., Gianchandani, R., MacMaster, H., Maynard, G. A., Murad, M. H., Seaquist, E., Wolfsdorf, J. I., Wright, R. F., & Wiercioch, W. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac596 · Cited by 123
16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s016 · Cited by 80
Inpatient Hypoglycemia: The Challenge Remains
Cruz, P. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820918540 · Cited by 73
Golden, S. H., Maruthur, N. M., Mathioudakis, N. N., Spanakis, E. K., Rubin, D. J., Zilbermint, M. F., & Hill‐Briggs, F. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0875-2 · Cited by 76
Metadata
- Authors
- Aloi, J., Bode, B. W., Ullal, J., Chidester, P., McFarland, R. S., Bedingfield, A. E., Mabrey, M., Booth, R., Mumpower, A., & Wallia, A.
- Affiliations
- Wake Forest University Health Sciences (US)
- Atlanta Diabetes Associates (US)
- Eastern Virginia Medical School (US)
- Sentara Health, Norfolk, VA, USA
- Glytec, Waltham, MA, USA
- Mountain States Health Alliance, Johnson City, TN, USA
- Northwestern University (US)
- Corresponding author
- Aloi, Joseph
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2016-09-25
- Volume
- 11
- Issue
- 1
- Pages
- 12-16
- ISSN
- 1932-2968 (ISSN-L)
- PMC
- PMC5375075
- OpenAlex
- W2508448858
- Cited by
- 39
- References
- 19
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 1 · 2023: 3 · 2022: 5 · 2021: 3 · 2020: 5 · 2019: 4 · 2018: 5 · 2017: 5 · 2016: 1
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Diabetes Science and Technology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- multiple daily insulin injections, subcutaneous insulin, hospitalized patients, glycemic control, hypoglycemia, blood glucose monitoring, diabetes management
- MeSH terms
- Adult, Aged, Algorithms, Blood Glucose, Female, Humans, Hypoglycemia, Hypoglycemic Agents, Injections, Subcutaneous, Inpatients, Insulin, Insulin Infusion Systems, Male, Middle Aged, Retrospective Studies, Incidence, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of an Electronic Glycemic Management System Versus Provider-Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital Setting. https://app.cochat.ai/papers/10.1177/1932296816664746
- The paper
- Aloi, J., Bode, B. W., Ullal, J., Chidester, P., McFarland, R. S., Bedingfield, A. E., Mabrey, M., Booth, R., Mumpower, A., & Wallia, A. (2017). Comparison of an Electronic Glycemic Management System Versus Provider-Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital Setting. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296816664746
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.